Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medicago Inc MDCGF

GREY:MDCGF - Post Discussion

Medicago Inc > Research report by Paradigm Capital
View:
Post by cbs123 on Oct 14, 2009 2:46pm

Research report by Paradigm Capital

Research report just released by Paradigm Capital calling for a price of $1.50 for Medicago in the next 12 months.  We wanted to alert our subscribers before the word gets out. 
 
This report is the first institutional coverage for Medicago and we are sure this is not the last.  The key point of the report highlight a potential revenue stream of over $600 million within the next 3 to 4 years.  They used a heavily discounted model to get this target price so there is a tremendous upside going forward.
Comment by TechnicalBuy on Oct 14, 2009 2:52pm
Please read our requirement to not post our letter without permission cbs123
Comment by Corkstown on Oct 15, 2009 9:45am
$0$0oui, demande pas la premiere fois cbs$0
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities